Aptorum Group (APM) Competitor Comparison
We are evaluating the key criteria listed to compare Aptorum Group (APM) against its competitors in the Biotechnology industry.
Market Capitalization
348 / 368Gross Profits
0 / 278Total Revenue
234 / 300EBITDA
64 / 337Free Cashflow
76 / 352Quick Ratio
345 / 357Earnings per Share
94 / 359Dividend yield
0 / 6Total Cash
353 / 358Performance 3 years
331 / 368Performance 5 years
357 / 368Performance 10 years
337 / 368Linearity 3 years
254 / 368Linearity 5 years
310 / 368Linearity 10 years
247 / 368Total Rank
127 / 368Dividend Rank
352 / 368Valuation Rank
75 / 368Piotroski Rank
128 / 368Muliplier Rank
271 / 368Muliplier Rank - APM ranking 271 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.